The Debrief: An AI Tool to Help You Quit Your Job

In partnership with

Welcome to The Debrief. This week we interviewed Saquib, an entrepreneur in the AI space who has created a tool which earns him thousands of dollars per month. If you didn’t catch it, feel free to check it out here before diving into this edition.

In this mid-week newsletter, we are going to investigate what we covered in our interview and breakdown the key takeaways and share some actionable advice for you to work on in your business venture.

Each debrief is designed to give you something to work on each week based off the advice given by our featured entrepreneur.

Let’s get into it!

The Flux Train

Key takeaways:

1. Bridging Technology with Creativity Can Open Lucrative Niches
   Saquib’s experience in both robotics research and the creative industry allowed him to identify a gap in generative AI for video production—specifically maintaining consistent characters across scenes. By addressing this challenge with his platform, TheFluxTrain, he’s revolutionising video creation. This highlights the value of combining technical expertise with creative insights to create innovative solutions.

2. Prioritising Early User Feedback and Content-Driven Marketing Pays Off

   The strategy of launching a minimal viable product (MVP) and gathering feedback early through platforms like Reddit enabled rapid iteration. Simultaneously, he used content-driven marketing, such as educational Medium articles, to provide value and build trust with their audience. This approach not only engaged users but also helped convert them into paying customers.

3. Leverage Existing Resources for Rapid Development
   By building on base code from previous projects, he built the app in just 4 days. This included key features like authentication and payment integration. This efficiency underscores the importance of leveraging prior experience and resources to minimise development time and focus on launching quickly.

📣 Something from our sponsor:

You can be part of a life-saving mission.

Invest in Cizzle Biotech’s groundbreaking early-detection blood test, designed to catch lung cancer before symptoms appear. With over 95% accuracy and strong backing from partners like Bio-Techne and Moffitt Cancer Center, our innovation has the potential to save millions of lives and transform healthcare. Join us in making early detection accessible—and take part in reshaping the future of medical diagnostics.

Join the Raise

^{Read the Offering information carefully before investing. It contains details of the issuer’s business, risks, charges, expenses, and other information, which should be considered before investing. Obtain a Form C and Offering Memorandum at invest.cizzlebio.com}

How to start this business?

Subscribe to our premium content to read the rest.